United States Biotechnology & Medical Research

Syndax Pharmaceuticals Inc (SNDX)

Track

Track

Syndax Pharmaceuticals experienced nine insider trading transactions recently, totaling over 5.6 million dollars in sales. Key executives, including the CEO and R&D head, offloaded shares through planned divestments. These activities occurred amidst a 16.2 percent stock price increase over ninety days, following a recent earnings report that missed expectations.
Ticker: SNDX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Syndax Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
287.00
Quantity 35,611 +24.3%
Value US$3,391,627
2.7
MICHAEL METZGER Director; Officer Executive Director
Transaction date
Proposed sale
Price
363.77
Quantity 56,312
Value US$4,869,289
3.3
Botwood Nicholas A.J. Head of R&D, CMO Officer
Transaction date
Planned sale
Price
84.99
Quantity 42,496 -20.7%
Value US$4,046,635
3.3
Botwood Nicholas A.J. Head of R&D, CMO Officer
Transaction date
Planned sale
Price
18.14
Quantity 31,235 -33.9%
Value US$566,603
3.3
Botwood Nicholas A.J. Officer Officer
Transaction date
Proposed sale
Price
18.14
Quantity 31,235
Value US$566,693
3.3
Botwood Nicholas A.J. Head of R&D, CMO Officer
Transaction date
Planned sale
Price
18.00
Quantity 34,280 -36.0%
Value US$617,040
3.3
Botwood Nicholas A.J. Head of R&D, CMO Officer
Transaction date
Planned sale
Price
18.00
Quantity 34,280 -36.0%
Value US$617,040
3.3
Botwood Nicholas A.J. Officer Officer
Transaction date
Proposed sale
Price
17.78
Quantity 34,280
Value US$609,435
3.3
Botwood Nicholas A.J. Officer Officer
Transaction date
Proposed sale
Price
17.78
Quantity 34,280
Value US$609,435
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Sale
Price
18.99
Quantity 6,847 -1.4%
Value US$130,025
2.0
Goldan Keith A. Chief Financial Officer Officer
Transaction date
Sale
Price
18.99
Quantity 1,177 -0.8%
Value US$22,351
2.0
Goldan Keith A. Officer Officer
Transaction date
Proposed sale
Price
18.99
Quantity 1,177
Value US$22,352
2.7
Metzger Michael A Officer; Director Executive Director
Transaction date
Proposed sale
Price
18.99
Quantity 6,847
Value US$130,028
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Sale
Price
21.03
Quantity 17,159 -3.4%
Value US$360,819
2.0
Goldan Keith A. Chief Financial Officer Officer
Transaction date
Sale
Price
21.03
Quantity 3,410 -2.4%
Value US$71,705
2.7
Metzger Michael A Officer; Director Executive Director
Transaction date
Proposed sale
Price
21.03
Quantity 17,159
Value US$360,826
2.0
Goldan Keith A. Officer Officer
Transaction date
Proposed sale
Price
21.03
Quantity 3,410
Value US$71,707
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Sale
Price
20.62
Quantity 7,412 -1.4%
Value US$152,835
2.0
Goldan Keith A. Chief Financial Officer Officer
Transaction date
Sale
Price
20.62
Quantity 2,082 -1.4%
Value US$42,931
2.7
Metzger Michael A Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.62
Quantity 7,412
Value US$152,836
2.0
Goldan Keith A. Officer Officer
Transaction date
Proposed sale
Price
20.62
Quantity 2,082
Value US$42,931
2.7
MICHAEL METZGER Director; Officer Executive Director
Transaction date
Proposed sale
Price
17.04
Quantity 157,307
Value US$2,680,511
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
16.41
Quantity 157,307 -34.5%
Value US$2,582,021
3.0
DENNIS G PODLESAK Director Non-Executive Director
Transaction date
Proposed sale
Price
15.74
Quantity 14,400
Value US$226,656
3.0
Podlesak Dennis Non-Executive Director
Transaction date
Planned sale
Price
15.84
Quantity 19,200 -9.1%
Value US$304,170
3.0
Podlesak Dennis Non-Executive Director
Transaction date
Planned sale
Price
15.54
Quantity 19,200 -9.1%
Value US$298,408
3.0
Podlesak Dennis Non-Executive Director
Transaction date
Planned sale
Price
14.19
Quantity 19,200 -9.1%
Value US$272,521
3.0
DENNIS G PODLESAK Director Non-Executive Director
Transaction date
Proposed sale
Price
13.45
Quantity 43,200
Value US$581,040
2.0
Goldan Keith A. Chief Financial Officer Officer
Transaction date
Sale
Price
9.29
Quantity 1,296 -1.4%
Value US$12,033
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Sale
Price
9.29
Quantity 7,534 -2.5%
Value US$69,953
2.0
Goldan Keith A. Officer Officer
Transaction date
Proposed sale
Price
9.29
Quantity 1,296
Value US$12,034
2.7
Metzger Michael A Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.29
Quantity 7,534
Value US$69,955
3.2
Gallagher Neil Officer Officer
Transaction date
Proposed sale
Price
9.26
Quantity 9,679
Value US$89,667
3.2
Katkin Keith Non-Executive Director
Transaction date
Purchase
Price
9.11
Quantity 10,000 +11.1%
Value US$91,120
3.2
Huber Martin H. Jr. Non-Executive Director
Transaction date
Purchase
Price
8.99
Quantity 5,000 +6.8%
Value US$44,950
3.3
Botwood Nicholas A.J. Head of R&D, CMO Officer
Transaction date
Purchase
Price
9.00
Quantity 11,765 +50.3%
Value US$105,826
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.05
Quantity 7,814 -2.5%
Value US$117,564
2.7
MICHAEL METZGER Officer Officer
Transaction date
Proposed sale
Price
15.48
Quantity 13,888
Value US$214,986
3.2
Gallagher Neil President, Head of R&D Officer
Transaction date
Sale
Price
15.50
Quantity 4,618 -5.1%
Value US$71,597
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Sale
Price
15.50
Quantity 13,288 -4.2%
Value US$206,017
2.0
Goldan Keith A. Chief Financial Officer Officer
Transaction date
Sale
Price
15.50
Quantity 3,777 -4.0%
Value US$58,559
2.0
Goldan Keith A. Officer Officer
Transaction date
Proposed sale
Price
15.50
Quantity 3,777
Value US$58,559
2.7
Metzger Michael A Officer; Director Executive Director
Transaction date
Proposed sale
Price
15.50
Quantity 13,288
Value US$206,017
3.2
Gallagher Neil Officer Officer
Transaction date
Proposed sale
Price
15.50
Quantity 4,618
Value US$71,597
2.0
Goldan Keith A. Chief Financial Officer Officer
Transaction date
Purchase
Price
20.03
Quantity 1,250 +2.4%
Value US$25,037
3.3
Morrison Briggs Non-Executive Director
Transaction date
Sale
Price
18.27
Quantity 52,855 -74.8%
Value US$965,402
3.3
BRIGGS MORRISON Director Non-Executive Director
Transaction date
Proposed sale
Price
18.25
Quantity 52,855
Value US$964,604
3.1
Meury William Non-Executive Director
Transaction date
Sale
Price
20.45
Quantity 24,000 -33.3%
Value US$490,913
3.1
Meury William Non-Executive Director
Transaction date
Sale
Price
20.46
Quantity 24,000 -33.3%
Value US$490,951
3.1
Meury William Non-Executive Director
Transaction date
Sale
Price
20.46
Quantity 35,000 -42.2%
Value US$715,946
3.1
Meury William Director Non-Executive Director
Transaction date
Proposed sale
Price
20.46
Quantity 83,000
Value US$1,697,811
3.3
Morrison Briggs Non-Executive Director
Transaction date
Sale
Price
20.40
Quantity 52,855 -74.8%
Value US$1,078,068
3.3
BRIGGS MORRISON Director Non-Executive Director
Transaction date
Proposed sale
Price
20.30
Quantity 52,855
Value US$1,072,956
2.0
Goldan Keith A. Chief Financial Officer Officer
Transaction date
Sale
Price
22.31
Quantity 577 -18.0%
Value US$12,873
3.3
BRIGGS W MORRISON Director Non-Executive Director
Transaction date
Proposed sale
Price
21.32
Quantity 52,855
Value US$1,126,869
3.3
Morrison Briggs Non-Executive Director
Transaction date
Sale
Price
21.18
Quantity 28,273 -61.3%
Value US$598,797
3.3
Morrison Briggs Non-Executive Director
Transaction date
Sale
Price
21.18
Quantity 24,582 -34.8%
Value US$520,625
3.3
Morrison Briggs Non-Executive Director
Transaction date
Sale
Price
21.41
Quantity 52,855 -74.8%
Value US$1,131,478
3.3
Morrison Briggs Non-Executive Director
Transaction date
Sale
Price
19.53
Quantity 52,855 -74.8%
Value US$1,032,237
3.3
Morrison Briggs President, Head of R&D Executive Director
Transaction date
Planned sale
Price
22.53
Quantity 52,854 -74.8%
Value US$1,190,674
2.1
Ordentlich Peter Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.84
Quantity 17,428 -100.0%
Value US$450,404
2.1
Ordentlich Peter Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.84
Quantity 7,572 -100.0%
Value US$195,688
3.3
Morrison Briggs President, Head of R&D Executive Director
Transaction date
Planned sale
Price
26.83
Quantity 52,854 -74.8%
Value US$1,417,909
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.64
Quantity 5,959 -25.2%
Value US$164,697
2.1
Ordentlich Peter Chief Scientific Officer Officer
Transaction date
Sale
Price
28.43
Quantity 69 -100.0%
Value US$1,962
1.5
Legault Pierre Non-Executive Director
Transaction date
Planned sale
Price
27.00
Quantity 5,000 -13.5%
Value US$135,000
1.5
Legault Pierre Non-Executive Director
Transaction date
Planned sale
Price
27.00
Quantity 10,000 -23.8%
Value US$270,000
1.5
Legault Pierre Non-Executive Director
Transaction date
Planned sale
Price
26.74
Quantity 24,000 -42.9%
Value US$641,782
2.1
Ordentlich Peter Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.05
Quantity 17,200 -98.5%
Value US$430,936
2.1
Ordentlich Peter Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.01
Quantity 4,028 -93.8%
Value US$100,746
2.1
Ordentlich Peter Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.01
Quantity 3,772 -93.4%
Value US$94,343
3.2
Katkin Keith Non-Executive Director
Transaction date
Planned sale
Price
25.90
Quantity 9,117 -22.2%
Value US$236,139
3.2
Katkin Keith Non-Executive Director
Transaction date
Planned sale
Price
25.90
Quantity 20,782 -39.4%
Value US$538,273
2.7
Metzger Michael A Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
25.29
Quantity 16,231 -47.9%
Value US$410,508
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-09 2026-07-08 PlS Planned sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
35,611 +24.3%
287.00
US$3,391,627 		35,611 +24.3% 287.00 US$3,391,627
2026-07-08 2026-07-08 PrS Proposed sale
2.7
MICHAEL METZGER

Director; Officer

Executive Director
56,312
363.77
US$4,869,289 		56,312 363.77 US$4,869,289
2026-06-12 2026-06-12 PlS Planned sale
3.3
Botwood Nicholas A.J.

Head of R&D, CMO

Officer
42,496 -20.7%
84.99
US$4,046,635 		42,496 -20.7% 84.99 US$4,046,635
2026-06-12 2026-06-12 PlS Planned sale
3.3
Botwood Nicholas A.J.

Head of R&D, CMO

Officer
31,235 -33.9%
18.14
US$566,603 		31,235 -33.9% 18.14 US$566,603
2026-06-12 2026-06-12 PrS Proposed sale
3.3
Botwood Nicholas A.J.

Officer

Officer
31,235
18.14
US$566,693 		31,235 18.14 US$566,693
2026-06-12 2026-06-11 PlS Planned sale
3.3
Botwood Nicholas A.J.

Head of R&D, CMO

Officer
34,280 -36.0%
18.00
US$617,040 		34,280 -36.0% 18.00 US$617,040
2026-06-12 2026-06-11 PlS Planned sale
3.3
Botwood Nicholas A.J.

Head of R&D, CMO

Officer
34,280 -36.0%
18.00
US$617,040 		34,280 -36.0% 18.00 US$617,040
2026-06-11 2026-06-11 PrS Proposed sale
3.3
Botwood Nicholas A.J.

Officer

Officer
34,280
17.78
US$609,435 		34,280 17.78 US$609,435
2026-06-11 2026-06-11 PrS Proposed sale
3.3
Botwood Nicholas A.J.

Officer

Officer
34,280
17.78
US$609,435 		34,280 17.78 US$609,435
2026-06-02 2026-06-01 S Sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
6,847 -1.4%
18.99
US$130,025 		6,847 -1.4% 18.99 US$130,025
2026-06-02 2026-06-01 S Sale
2.0
Goldan Keith A.

Chief Financial Officer

Officer
1,177 -0.8%
18.99
US$22,351 		1,177 -0.8% 18.99 US$22,351
2026-06-01 2026-06-01 PrS Proposed sale
2.0
Goldan Keith A.

Officer

Officer
1,177
18.99
US$22,352 		1,177 18.99 US$22,352
2026-06-01 2026-06-01 PrS Proposed sale
2.7
Metzger Michael A

Officer; Director

Executive Director
6,847
18.99
US$130,028 		6,847 18.99 US$130,028
2026-02-10 2026-02-09 S Sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
17,159 -3.4%
21.03
US$360,819 		17,159 -3.4% 21.03 US$360,819
2026-02-10 2026-02-09 S Sale
2.0
Goldan Keith A.

Chief Financial Officer

Officer
3,410 -2.4%
21.03
US$71,705 		3,410 -2.4% 21.03 US$71,705
2026-02-09 2026-02-09 PrS Proposed sale
2.7
Metzger Michael A

Officer; Director

Executive Director
17,159
21.03
US$360,826 		17,159 21.03 US$360,826
2026-02-09 2026-02-09 PrS Proposed sale
2.0
Goldan Keith A.

Officer

Officer
3,410
21.03
US$71,707 		3,410 21.03 US$71,707
2026-02-06 2026-02-06 S Sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
7,412 -1.4%
20.62
US$152,835 		7,412 -1.4% 20.62 US$152,835
2026-02-06 2026-02-06 S Sale
2.0
Goldan Keith A.

Chief Financial Officer

Officer
2,082 -1.4%
20.62
US$42,931 		2,082 -1.4% 20.62 US$42,931
2026-02-06 2026-02-06 PrS Proposed sale
2.7
Metzger Michael A

Officer; Director

Executive Director
7,412
20.62
US$152,836 		7,412 20.62 US$152,836
2026-02-06 2026-02-06 PrS Proposed sale
2.0
Goldan Keith A.

Officer

Officer
2,082
20.62
US$42,931 		2,082 20.62 US$42,931
2025-09-08 2025-09-08 PrS Proposed sale
2.7
MICHAEL METZGER

Director; Officer

Executive Director
157,307
17.04
US$2,680,511 		157,307 17.04 US$2,680,511
2025-09-08 2025-09-08 PlS Planned sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
157,307 -34.5%
16.41
US$2,582,021 		157,307 -34.5% 16.41 US$2,582,021
2025-08-18 2025-08-18 PrS Proposed sale
3.0
DENNIS G PODLESAK

Director

Non-Executive Director
14,400
15.74
US$226,656 		14,400 15.74 US$226,656
2025-08-18 2025-08-18 PlS Planned sale
3.0
Podlesak Dennis
Non-Executive Director
19,200 -9.1%
15.84
US$304,170 		19,200 -9.1% 15.84 US$304,170
2025-08-18 2025-08-15 PlS Planned sale
3.0
Podlesak Dennis
Non-Executive Director
19,200 -9.1%
15.54
US$298,408 		19,200 -9.1% 15.54 US$298,408
2025-08-18 2025-08-14 PlS Planned sale
3.0
Podlesak Dennis
Non-Executive Director
19,200 -9.1%
14.19
US$272,521 		19,200 -9.1% 14.19 US$272,521
2025-08-14 2025-08-14 PrS Proposed sale
3.0
DENNIS G PODLESAK

Director

Non-Executive Director
43,200
13.45
US$581,040 		43,200 13.45 US$581,040
2025-07-18 2025-07-16 S Sale
2.0
Goldan Keith A.

Chief Financial Officer

Officer
1,296 -1.4%
9.29
US$12,033 		1,296 -1.4% 9.29 US$12,033
2025-07-18 2025-07-16 S Sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
7,534 -2.5%
9.29
US$69,953 		7,534 -2.5% 9.29 US$69,953
2025-07-16 2025-07-16 PrS Proposed sale
2.0
Goldan Keith A.

Officer

Officer
1,296
9.29
US$12,034 		1,296 9.29 US$12,034
2025-07-16 2025-07-16 PrS Proposed sale
2.7
Metzger Michael A

Officer; Director

Executive Director
7,534
9.29
US$69,955 		7,534 9.29 US$69,955
2025-07-10 2025-07-10 PrS Proposed sale
3.2
Gallagher Neil

Officer

Officer
9,679
9.26
US$89,667 		9,679 9.26 US$89,667
2025-05-19 2025-05-19 B Purchase
3.2
Katkin Keith
Non-Executive Director
10,000 +11.1%
9.11
US$91,120 		10,000 +11.1% 9.11 US$91,120
2025-05-19 2025-05-19 B Purchase
3.2
Huber Martin H. Jr.
Non-Executive Director
5,000 +6.8%
8.99
US$44,950 		5,000 +6.8% 8.99 US$44,950
2025-05-19 2025-05-16 B Purchase
3.3
Botwood Nicholas A.J.

Head of R&D, CMO

Officer
11,765 +50.3%
9.00
US$105,826 		11,765 +50.3% 9.00 US$105,826
2025-03-06 2025-03-04 PlS Planned sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
7,814 -2.5%
15.05
US$117,564 		7,814 -2.5% 15.05 US$117,564
2025-03-04 2025-03-04 PrS Proposed sale
2.7
MICHAEL METZGER

Officer

Officer
13,888
15.48
US$214,986 		13,888 15.48 US$214,986
2025-02-12 2025-02-10 S Sale
3.2
Gallagher Neil

President, Head of R&D

Officer
4,618 -5.1%
15.50
US$71,597 		4,618 -5.1% 15.50 US$71,597
2025-02-12 2025-02-10 S Sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
13,288 -4.2%
15.50
US$206,017 		13,288 -4.2% 15.50 US$206,017
2025-02-12 2025-02-10 S Sale
2.0
Goldan Keith A.

Chief Financial Officer

Officer
3,777 -4.0%
15.50
US$58,559 		3,777 -4.0% 15.50 US$58,559
2025-02-10 2025-02-10 PrS Proposed sale
2.0
Goldan Keith A.

Officer

Officer
3,777
15.50
US$58,559 		3,777 15.50 US$58,559
2025-02-10 2025-02-10 PrS Proposed sale
2.7
Metzger Michael A

Officer; Director

Executive Director
13,288
15.50
US$206,017 		13,288 15.50 US$206,017
2025-02-10 2025-02-10 PrS Proposed sale
3.2
Gallagher Neil

Officer

Officer
4,618
15.50
US$71,597 		4,618 15.50 US$71,597
2024-06-17 2024-06-14 B Purchase
2.0
Goldan Keith A.

Chief Financial Officer

Officer
1,250 +2.4%
20.03
US$25,037 		1,250 +2.4% 20.03 US$25,037
2023-08-10 2023-08-09 S Sale
3.3
Morrison Briggs
Non-Executive Director
52,855 -74.8%
18.27
US$965,402 		52,855 -74.8% 18.27 US$965,402
2023-08-09 2023-08-09 PrS Proposed sale
3.3
BRIGGS MORRISON

Director

Non-Executive Director
52,855
18.25
US$964,604 		52,855 18.25 US$964,604
2023-08-03 2023-08-02 S Sale
3.1
Meury William
Non-Executive Director
24,000 -33.3%
20.45
US$490,913 		24,000 -33.3% 20.45 US$490,913
2023-08-03 2023-08-02 S Sale
3.1
Meury William
Non-Executive Director
24,000 -33.3%
20.46
US$490,951 		24,000 -33.3% 20.46 US$490,951
2023-08-03 2023-08-02 S Sale
3.1
Meury William
Non-Executive Director
35,000 -42.2%
20.46
US$715,946 		35,000 -42.2% 20.46 US$715,946
2023-08-02 2023-08-02 PrS Proposed sale
3.1
Meury William

Director

Non-Executive Director
83,000
20.46
US$1,697,811 		83,000 20.46 US$1,697,811
2023-07-11 2023-07-10 S Sale
3.3
Morrison Briggs
Non-Executive Director
52,855 -74.8%
20.40
US$1,078,068 		52,855 -74.8% 20.40 US$1,078,068
2023-07-10 2023-07-10 PrS Proposed sale
3.3
BRIGGS MORRISON

Director

Non-Executive Director
52,855
20.30
US$1,072,956 		52,855 20.30 US$1,072,956
2023-06-14 2023-06-13 S Sale
2.0
Goldan Keith A.

Chief Financial Officer

Officer
577 -18.0%
22.31
US$12,873 		577 -18.0% 22.31 US$12,873
2023-06-09 2023-06-09 PrS Proposed sale
3.3
BRIGGS W MORRISON

Director

Non-Executive Director
52,855
21.32
US$1,126,869 		52,855 21.32 US$1,126,869
2023-06-09 2023-06-09 S Sale
3.3
Morrison Briggs
Non-Executive Director
28,273 -61.3%
21.18
US$598,797 		28,273 -61.3% 21.18 US$598,797
2023-06-09 2023-06-09 S Sale
3.3
Morrison Briggs
Non-Executive Director
24,582 -34.8%
21.18
US$520,625 		24,582 -34.8% 21.18 US$520,625
2023-05-10 2023-05-09 S Sale
3.3
Morrison Briggs
Non-Executive Director
52,855 -74.8%
21.41
US$1,131,478 		52,855 -74.8% 21.41 US$1,131,478
2023-05-09 2023-05-09 PrS Proposed sale
3.3
BRIGGS W MORRISON &ANGELA HOOVER MORRISON JT TEN

Officer

Officer
52,855
20.29
US$1,072,428 		52,855 20.29 US$1,072,428
2023-04-12 2023-04-10 S Sale
3.3
Morrison Briggs
Non-Executive Director
52,855 -74.8%
19.53
US$1,032,237 		52,855 -74.8% 19.53 US$1,032,237
2023-03-14 2023-03-13 PlS Planned sale
3.3
Morrison Briggs

President, Head of R&D

Executive Director
52,854 -74.8%
22.53
US$1,190,674 		52,854 -74.8% 22.53 US$1,190,674
2023-02-17 2023-02-15 PlS Planned sale
2.1
Ordentlich Peter

Chief Scientific Officer

Officer
17,428 -100.0%
25.84
US$450,404 		17,428 -100.0% 25.84 US$450,404
2023-02-17 2023-02-15 PlS Planned sale
2.1
Ordentlich Peter

Chief Scientific Officer

Officer
7,572 -100.0%
25.84
US$195,688 		7,572 -100.0% 25.84 US$195,688
2023-02-08 2023-02-06 PlS Planned sale
3.3
Morrison Briggs

President, Head of R&D

Executive Director
52,854 -74.8%
26.83
US$1,417,909 		52,854 -74.8% 26.83 US$1,417,909
2023-02-08 2023-02-06 PlS Planned sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
5,959 -25.2%
27.64
US$164,697 		5,959 -25.2% 27.64 US$164,697
2023-02-03 2023-02-01 S Sale
2.1
Ordentlich Peter

Chief Scientific Officer

Officer
69 -100.0%
28.43
US$1,962 		69 -100.0% 28.43 US$1,962
2023-01-13 2023-01-13 PlS Planned sale
1.5
Legault Pierre
Non-Executive Director
5,000 -13.5%
27.00
US$135,000 		5,000 -13.5% 27.00 US$135,000
2023-01-13 2023-01-13 PlS Planned sale
1.5
Legault Pierre
Non-Executive Director
10,000 -23.8%
27.00
US$270,000 		10,000 -23.8% 27.00 US$270,000
2023-01-13 2023-01-12 PlS Planned sale
1.5
Legault Pierre
Non-Executive Director
24,000 -42.9%
26.74
US$641,782 		24,000 -42.9% 26.74 US$641,782
2022-12-02 2022-12-02 PlS Planned sale
2.1
Ordentlich Peter

Chief Scientific Officer

Officer
17,200 -98.5%
25.05
US$430,936 		17,200 -98.5% 25.05 US$430,936
2022-12-02 2022-12-01 PlS Planned sale
2.1
Ordentlich Peter

Chief Scientific Officer

Officer
4,028 -93.8%
25.01
US$100,746 		4,028 -93.8% 25.01 US$100,746
2022-12-02 2022-12-01 PlS Planned sale
2.1
Ordentlich Peter

Chief Scientific Officer

Officer
3,772 -93.4%
25.01
US$94,343 		3,772 -93.4% 25.01 US$94,343
2022-10-07 2022-10-06 PlS Planned sale
3.2
Katkin Keith
Non-Executive Director
9,117 -22.2%
25.90
US$236,139 		9,117 -22.2% 25.90 US$236,139
2022-10-07 2022-10-06 PlS Planned sale
3.2
Katkin Keith
Non-Executive Director
20,782 -39.4%
25.90
US$538,273 		20,782 -39.4% 25.90 US$538,273
2022-10-07 2022-10-06 PlS Planned sale
2.7
Metzger Michael A

Chief Executive Officer

Executive Director
16,231 -47.9%
25.29
US$410,508 		16,231 -47.9% 25.29 US$410,508
Explore more

More insider trading research around Syndax Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America